Part C. Fees  


SubPart 1. freedom of information fees
§ 379f. Recovery and retention of fees for freedom of information requests
SubPart 2. fees relating to drugs
§ 379g. Definitions
§ 379h. Authority to assess and use drug fees
§ 379h–1. Fees relating to advisory review of prescription-drug television advertising
§ 379h–2. Reauthorization; reporting requirements
SubPart 3. fees relating to devices
§ 379i. Definitions
§ 379j. Authority to assess and use device fees
§ 379j–1. Reauthorization; reporting requirements
SubPart 4. fees relating to animal drugs
§ 379j–11. Definitions
§ 379j–12. Authority to assess and use animal drug fees
§ 379j–13. Reauthorization; reporting requirements
SubPart 5. fees relating to generic new animal drugs
§ 379j–21. Authority to assess and use generic new animal drug fees
§ 379j–22. Reauthorization; reporting requirements
SubPart 6. fees related to food
§ 379j–31. Authority to collect and use fees
SubPart 7. fees relating to generic drugs
§ 379j–41. Definitions
§ 379j–42. Authority to assess and use human generic drug fees
§ 379j–43. Reauthorization; reporting requirements
SubPart 8. fees relating to biosimilar biological products
§ 379j–51. Definitions
§ 379j–52. Authority to assess and use biosimilar biological product fees
§ 379j–53. Reauthorization; reporting requirements
SubPart 9. fees relating to outsourcing facilities
§ 379j–61. Definitions
§ 379j–62. Authority to assess and use outsourcing facility fees